Gaithersburg, Maryland, USA and Hyderabad, Andhra Pradesh, India, April 08, 2011: Gene Logic, the leading provider of reference gene expression database solutions, today announced that user licenses of its award-winning ASCENTA System are now offered at special academic pricing to all academic and non-profit organizations to encourage innovation in the industry.
Ms. Anu Acharya, CEO of Ocimum Biosolutions said “Having developed solutions for organizations across various sectors that include drug discovery, agriculture, nutraceuticals, and metagenomics, we recently launched ASCENTA 4.0 which comes fully loaded with more data and improved features that helps the researchers to study and analyze their genes of interest”. She further added “Innovation in academia is what drives our industry. Ascenta can be an extremely powerful tool to accelerate scientific discoveries by academia and we would like to catalyze it by offering it at a special price to commemorate 10 years of Ocimum”.
Detailed licensing information can be obtained by contacting firstname.lastname@example.org. Also, one week free trials are available via registration on http://www.genelogic.com/wp-content/forms/triallicense.htm
About ASCENTA System
ASCENTA is web-based and was developed to simplify access to and information retrieval from BioExpressTM, Gene Logic’s proprietary database that is the most comprehensive gene expression database in the world today. ASCENTA makes it possible for researchers to quickly identify and prioritize drug targets and biomarkers across multiple disease and tissue settings. In the past seven years ASCENTA System has been instrumental in the discovery and validation of several drug targets and biomarkers.
About Ocimum Biosolutions
Ocimum Biosolutions is a global integrated genomic services company with operations in Hyderabad, India, and Gaithersburg, MD (Gene Logic). We provide comprehensive (research level and clinical GLP-compliant) genomic services, reference databases, and LIMS solutions. Our distinct platform “Research as a Service” (RaaS) allows complete outsourcing of genomics – from storing biological samples and performing on demand DNA and RNA based services to validating biomarkers using our proprietary databases and providing data and bioinformatic analysis. We have been chosen as a global preferred outsourcing provider for most of the top 25 pharma and biotech companies plus leading research institutes. Our partners recognize our wide-ranging expertise in genomics and genetic sciences, discovery and evaluation of gene targets and biomarkers, and sample analysis for clinical studies.
For more information, please visit www.ocimumbio.com.